233 related articles for article (PubMed ID: 12370003)
1. Anthrax fusion protein therapy of cancer.
Frankel AE; Powell BL; Duesbery NS; Vande Woude GF; Leppla SH
Curr Protein Pept Sci; 2002 Aug; 3(4):399-407. PubMed ID: 12370003
[TBL] [Abstract][Full Text] [Related]
2. Tumor Targeting and Drug Delivery by Anthrax Toxin.
Bachran C; Leppla SH
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376328
[TBL] [Abstract][Full Text] [Related]
3. Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy.
Mathew M; Verma RS
Cancer Sci; 2009 Aug; 100(8):1359-65. PubMed ID: 19459847
[TBL] [Abstract][Full Text] [Related]
4. Bismaleimide cross-linked anthrax toxin forms functional octamers with high specificity in tumor targeting.
Fischer ES; Campbell WA; Liu S; Ghirlando R; Fattah RJ; Bugge TH; Leppla SH
Protein Sci; 2019 Jun; 28(6):1059-1070. PubMed ID: 30942916
[TBL] [Abstract][Full Text] [Related]
5. Immunological and functional comparison between Clostridium perfringens iota toxin, C. spiroforme toxin, and anthrax toxins.
Perelle S; Scalzo S; Kochi S; Mock M; Popoff MR
FEMS Microbiol Lett; 1997 Jan; 146(1):117-21. PubMed ID: 8997715
[TBL] [Abstract][Full Text] [Related]
6. Alternative pre-approved and novel therapies for the treatment of anthrax.
Head BM; Rubinstein E; Meyers AF
BMC Infect Dis; 2016 Nov; 16(1):621. PubMed ID: 27809794
[TBL] [Abstract][Full Text] [Related]
7. Where and how do anthrax toxins exit endosomes to intoxicate host cells?
Puhar A; Montecucco C
Trends Microbiol; 2007 Nov; 15(11):477-82. PubMed ID: 17983750
[TBL] [Abstract][Full Text] [Related]
8. Cancer-homing toxins.
Ng HC; Khoo HE
Curr Pharm Des; 2002; 8(22):1973-85. PubMed ID: 12171523
[TBL] [Abstract][Full Text] [Related]
9. Peptide Probes Reveal a Hydrophobic Steric Ratchet in the Anthrax Toxin Protective Antigen Translocase.
Colby JM; Krantz BA
J Mol Biol; 2015 Nov; 427(22):3598-3606. PubMed ID: 26363343
[TBL] [Abstract][Full Text] [Related]
10. Bacterial Toxins for Cancer Therapy.
Zahaf NI; Schmidt G
Toxins (Basel); 2017 Jul; 9(8):. PubMed ID: 28788054
[TBL] [Abstract][Full Text] [Related]
11. Interactions between anthrax toxin receptors and protective antigen.
Scobie HM; Young JA
Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
[TBL] [Abstract][Full Text] [Related]
12. Potent antitumor activity of a urokinase-activated engineered anthrax toxin.
Liu S; Aaronson H; Mitola DJ; Leppla SH; Bugge TH
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):657-62. PubMed ID: 12525700
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
[TBL] [Abstract][Full Text] [Related]
14. Solid tumor therapy by selectively targeting stromal endothelial cells.
Liu S; Liu J; Ma Q; Cao L; Fattah RJ; Yu Z; Bugge TH; Finkel T; Leppla SH
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4079-87. PubMed ID: 27357689
[TBL] [Abstract][Full Text] [Related]
15. Patents on immunotoxins and chimeric toxins for the treatment of cancer.
Bachran C; Sutherland M; Bachran D; Fuchs H
Recent Pat Drug Deliv Formul; 2007; 1(2):105-15. PubMed ID: 19075878
[TBL] [Abstract][Full Text] [Related]
16. Anthrax toxin: the long and winding road that leads to the kill.
Abrami L; Reig N; van der Goot FG
Trends Microbiol; 2005 Feb; 13(2):72-8. PubMed ID: 15680766
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Effects of a Reengineered Anthrax Toxin on Canine Oral Mucosal Melanomas.
Nishiya AT; Nagamine MK; Fonseca IIMD; Miraldo AC; Scattone NV; Guerra JL; Xavier JG; Santos M; Gomes COMS; Ward JM; Liu S; Leppla SH; Bugge TH; Dagli MLZ
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32121654
[TBL] [Abstract][Full Text] [Related]
18. Immunotoxins in cancer therapy.
Kreitman RJ
Curr Opin Immunol; 1999 Oct; 11(5):570-8. PubMed ID: 10508704
[TBL] [Abstract][Full Text] [Related]
19. Clinical studies with targeted toxins in malignant glioma.
Rainov NG; Söling A
Rev Recent Clin Trials; 2006 May; 1(2):119-31. PubMed ID: 18473963
[TBL] [Abstract][Full Text] [Related]
20. Immunotoxins for targeted cancer therapy.
Kreitman RJ
AAPS J; 2006 Aug; 8(3):E532-51. PubMed ID: 17025272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
